Dynamic quotes: Off
|
ETFs with PRXL as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 3.91% | PowerShares Exchange-Traded Fund Trust II PowerShares S&P Smal (PSCH) | +5.75 (15.20%) |
| 0.9% | First Trust Small Cap Growth AlphaDEX Fund (FYC) | +2.80 (12.50%) |
| 0% | Ranger Equity Bear Bear ETF (HDGE) | -1.54 (-8.82%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
PAREXEL is a leading biopharmaceutical services company, providing a broad range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Our primary objective is to provide quality solutions for managing the biopharmaceutical product lifecycle with the goal of reducing the time, risk, and cost associated with the development and commercialization of new therapies. Since our incorporation in 1983, we have developed significant expertise in processes and technologies supporting this strategy. ... More ...
Analyst Info |
|
| Annual EPS Est: | $1.1 |
| Quarterly EPS Est: | 0.43 |
| PEG Ratio: | 1.53 |
|
Mean Recommendation: View Summary / View All |
1.89 |
Data is provided by Zacks Investment Research
